The field of red cell biology is undergoing a quiet revolution. Long assumed to be inert oxygen carriers, RBCs are emerging as important modulators of the innate immune response. Erythrocytes bind and scavenge chemokines, nucleic acids, and pathogens in circulation. Depending on the conditions of the microenvironment, erythrocytes may either promote immune activation or maintain immune quiescence. We examine erythrocyte immune function through a comparative and evolutionary lens, as this framework may offer perspective into newly recognized roles of human RBCs. Next, we review the known immune roles of human RBCs and discuss their activity in the context of sepsis where erythrocyte function may prove important to disease pathogenesis. Given the limited success of immunomodulatory therapies in treating inflammatory diseases, we propose that the immunologic function of RBCs provides an understudied and potentially rich area of research that may yield novel insights into mechanisms of immune regulation.

Erythrocytes are the most abundant cell type in the human body, numbering between 20 and 30 trillion and accounting for nearly 70% of the total cell count in the average adult (1). Erythropoiesis begins with the differentiation of multipotent hematopoietic stem cells in the bone marrow, which then give rise to erythroid-committed precursors. In the final stages of the process, known as terminal erythropoiesis, the nucleus and other organelles are extruded. These enucleated reticulocytes are then released into the bloodstream to complete their maturation process (2). After a lifespan of ∼120 d, RBCs are cleared by macrophages in the spleen and liver (3).

Importantly, mammals are the only vertebrates whose erythrocytes are enucleated in their mature state. The extrusion of the nucleus and other organelles occurs through a series of complex stages, including chromatin condensation, budding, and mitophagy (2, 4). Loss of the erythroid nucleus is thought to have facilitated the evolution of mammalian endothermy, as it allowed erythrocytes to further specialize for efficient gas exchange (4).

In the classical literature, human erythrocytes have long been typecast as mere oxygen transporters. However, mounting evidence suggests that these cells also play an important role in the innate immune system (57). From an evolutionary perspective, the involvement of human erythrocytes in innate immunity should not be surprising, as the nucleated erythrocytes of birds, amphibians, and fishes actively participate in the immune response via production of cytokine-like factors, upregulation of viral response genes, and sequestration of pathogens through surface binding or phagocytosis (820). Despite their deletion of organelles during erythropoiesis and subsequent inability to carry out transcription and translation, mammalian erythrocytes retain the ability to interact with endogenous and exogenous inflammatory molecules in the blood. Research over the past several decades demonstrates that, like their evolutionary counterparts, these cells retain the ability to bind and interact with a variety of inflammatory molecules, including chemokines, nucleic acids, and pathogens, thereby regulating and modulating immune responses. Internal components of erythrocytes such as hemoglobin and heme are also formidable facets of innate immunity, capable of generating antimicrobial reactive oxygen species (ROS) to defend against invading hemolytic microbes as well as promoting pathologic inflammatory and autoimmune responses. Finally, the involvement of erythrocytes in host–pathogen interactions may render them crucially important in the context of sepsis and septic shock, a state of dysregulated host response to infection where the body is overwhelmed with endotoxins and other inflammatory mediators. A deeper understanding of erythrocyte function will likely be vital to elucidating the ways in which these cells contribute to the pathogenesis of a variety of acute and chronic diseases.

Erythrocyte origins.

Throughout the course of evolution, the cellular components of the blood have undergone functional specialization. The earliest blood cells are thought to have been relative generalists involved in both phagocytosis and nutrient delivery. However, they did not serve a function in oxygen transport (21, 22). Prior to the emergence of circulatory systems, small invertebrates accomplished tissue oxygenation by simple diffusion alone; this mechanism is still observed today in primitive animals such as the sponges, cnidarians, and flatworms (21, 23). Later, the emergence of larger body plans necessitated more efficient oxygen delivery mechanisms, leading to the evolution of increasingly elaborate circulatory systems (23) and a variety of oxygen-carrying respiratory pigments (24, 25). Hemoglobin appears to have arisen first among them, followed by the hemerythrins, the molluscan hemocyanins, and eventually the arthropod hemocyanins (25). Although hemoglobin likely began as a free-floating protein, the emergence of cells to encapsulate the pigment (i.e., erythrocytes) appears to have occurred soon after (24, 25). All modern vertebrates [with the notable exception of white-blooded ice fish from the family Channichthyidae (26)] accomplish oxygen delivery by means of circulating hemoglobin-rich erythrocytes (24). Similar cells are sporadically observed in numerous invertebrate groups as well, including the echinoderms, phoronids, annelids, nemerteans, and mollusks (25, 27). Erythrocytes may have arisen separately in multiple animal lineages or once prior to the divergence of the animal phyla, although the precise evolutionary history remains unresolved (21, 22, 27).

Erythrocytes of nonmammalian vertebrates.

The erythrocytes of nonmammalian vertebrates are nucleated, save rare exceptions in the fishes (28) and amphibians (29, 30). Furthermore, like many other hematopoietic cells, nonmammalian erythrocytes directly participate in the immune response. In fishes (8, 16), amphibians (19), and birds (9, 13), erythrocytes actively undergo transcription and protein production in response to environmental cues. Specifically, Atlantic salmon (Salmo salar L.) erythrocytes increase transcription of Ag-presenting and viral response genes during piscine orthoreovirus infection and upregulate IFN-α in response to infectious salmon anemia virus, contributing to host resistance (10, 11). Erythrocytes in striped beakfish (Oplegnathus fasciatus) appear to coordinate immune function with leukocytes, upregulating an additional 338 genes when incubated with leukocytes and LPS compared with LPS alone (18). Furthermore, both chicken and trout erythrocytes release cytokine-like factors following exposure to fungal Ags (8, 9) and express functional pattern recognition receptors (including TLR and peptidoglycan recognition proteins) on their surfaces (14, 31). Remarkably, trout erythrocytes have even been observed engaging in phagocytosis of pathogenic yeast (Candida albicans) (12).

Finally, the erythrocytes of trout and chickens form cellular aggregations known as rosettes, which serve to expedite pathogen destruction by macrophages (12, 17). The rosetting behavior of piscine and avian erythrocytes stands in stark contrast to that of human erythrocytes, which is notoriously observed in severe cases of Plasmodium falciparum malaria. Rosetting in this context is characterized not as a defense mechanism of the human host but rather as a virulence mechanism of the malarial parasite (20). Infected erythrocytes adhering to uninfected erythrocytes and endothelial cells results in a sequestration of blood cells in affected organs, which, particularly when localized in cerebral tissue, is associated with mortality (20). It is possible that this rosetting behavior was co-opted by the malarial parasite or that it is the maladaptive consequence of an evolutionarily conserved mechanism of pathogen sequestration.

Mammalian erythrocytes.

Mammals are the only vertebrates with enucleated erythrocytes under homeostatic conditions (Fig. 1). Intriguingly, however, nucleated erythrocytes are sometimes observed in humans during pathologic states, constituting a striking exception and suggesting that enucleated erythrocytes are not an obligate feature of mammalian physiology (3234). Mammalian erythrocytes also lack endoplasmic reticula, ribosomes, and mitochondria, as early developmental processes expunge these typically vital organelles (2). It has been hypothesized that the deletion of nuclei and organelles in mature erythrocytes may have allowed for increased surface area–to-volume ratio, facilitating increased gas exchange efficiency (3537). Moreover, the feature allowed for elevated cellular hemoglobin capacity (4), increased pliability, and an improved ability to traverse small capillaries (15, 37).

FIGURE 1.

Comparing the immunologic properties of erythrocytes across vertebrate orders. The erythrocytes of lower vertebrates (i.e., fishes, amphibians, reptiles, and birds) are nucleated in their mature state. Erythrocytes of fish and birds are known to actively undergo transcription and translation, produce and release cytokines, form rosettes to sequester pathogens, and, in the case of trout, phagocytose pathogens. Although the activities of erythrocytes in reptiles and amphibians are less well studied, it is likely that they retain many of these characteristics given that they have been maintained across the phylogenetic distance from fish to birds. Despite lacking nuclei and organelles, mammalian (and human) erythrocytes retain the ability to influence innate immunity. All erythrocytes contain hemoglobin, which participates in host defense by generating antimicrobial ROS.

FIGURE 1.

Comparing the immunologic properties of erythrocytes across vertebrate orders. The erythrocytes of lower vertebrates (i.e., fishes, amphibians, reptiles, and birds) are nucleated in their mature state. Erythrocytes of fish and birds are known to actively undergo transcription and translation, produce and release cytokines, form rosettes to sequester pathogens, and, in the case of trout, phagocytose pathogens. Although the activities of erythrocytes in reptiles and amphibians are less well studied, it is likely that they retain many of these characteristics given that they have been maintained across the phylogenetic distance from fish to birds. Despite lacking nuclei and organelles, mammalian (and human) erythrocytes retain the ability to influence innate immunity. All erythrocytes contain hemoglobin, which participates in host defense by generating antimicrobial ROS.

Close modal

It is possible that erythrocyte enucleation evolved in response to a reduction in Earth’s atmospheric oxygen concentrations (35) or because of the increased metabolic demands of endothermy (37). In line with the latter hypothesis, erythrocytes are comparatively larger in ectothermic, phylogenetically lower organisms like fishes and herptiles (36, 38). The extrusion of mitochondria in mammalian erythrocytes may also have reduced production of damaging ROS (39). This is an attractive hypothesis given that human erythrocytes generate extensive free radicals even without mitochondria, necessitating their ample arsenal of protective antioxidant molecules and enzymes (40). However, avian erythrocytes exhibit lower levels of blood oxidative stress and similar cellular hemoglobin content in comparison with mammals, despite their retaining both functional mitochondria and nuclei (4, 41), indicating that the presence of mitochondria and nuclei in erythrocytes is not necessarily a barrier to endothermy. Because endothermy arose separately in the avian and mammalian lineages, it is perhaps to be expected that alternative suites of physiologic adaptations accompanied it.

Regardless of the specific pressures driving the loss of organelles in mammalian erythrocytes, the change appears to have been an evolutionary compromise: opting for greater respiratory specialization, the forfeiture of key cellular components rendered mammalian erythrocytes more passive actors than those of other vertebrates. Without ribosomes or a genome, mammalian erythrocytes are incapable of signal transduction, gene transcription, or new protein synthesis and are therefore unable to contribute to the immune response via de novo production of immunologically active signaling molecules. However, there is significant evidence that mammalian erythrocytes remain key contributors to innate immunity. Despite their loss of internal organelles, mammalian erythrocytes express a large number of cell surface receptors that mediate their interactions with both endogenous and exogenous agents in the blood (42), providing them with an extensive capacity for scavenging or sequestration of circulating molecules that impact immune function.

Hemoglobin and heme.

Among the respiratory pigments, hemoglobin is the most ancient (25). Circulating hemoglobin appears to have arisen from the tissue-localized hemoglobins of primitive animals, such as the turbellarian platyhelminths (25). Although oxygen carriage is their primary function, hemoglobin and free heme also participate in the innate immune response.

Because hemoglobin provides a rich source of iron for bacterial metabolism (4345), microbial invaders have evolved both hemolytic toxins and high-affinity scavenging systems to access it (4648). In response, host hemoglobin provides a counterattack: activated by the extracellular proteases of virulent bacteria, the peptide emits bactericidal ROS in the microbial vicinity (49). Studies show that both the α and β subunits of hemoglobin contain high-affinity binding sites for LPS, the immune-stimulating endotoxin present in the membranes of Gram-negative bacteria. When LPS binds to hemoglobin, it stimulates the redox activity of the peptide and leads to the production of antimicrobial free radicals (50). Additionally, the presence of hemoglobin has been shown to amplify macrophage cytokine production in the presence of LPS as well as enhance macrophage binding of LPS (51). Finally, micromolar concentrations of hemoglobin fragments are sufficient to inhibit the growth of yeast and bacteria (both Gram-positive and Gram-negative) via ROS production, while demonstrating no toxic effects on human blood cells (52).

The immunologic functions of respiratory globins are widespread across the animal kingdom. Invertebrate horseshoe crabs (Tachypleus tridentatus) contain blue-tinted blood rich in hemocyanin, a cell-free protein that carries oxygen throughout the blood of many mollusks and arthropods. In these animals, hemocyanin similarly generates ROS in response to microbial challenge (49, 53). The antimicrobial properties of globins are so universal that the cattle tick (Boophilus microplus) can appropriate fragments of its host’s hemoglobin for use in its own gut (54). Beyond their function in gas exchange, the utility of respiratory pigments as innate immune elements has been realized at multiple points throughout evolution (12, 25, 53).

Although hemoglobin may confer antimicrobial protection under homeostatic conditions, research indicates that it has the opposite effect during pathologic states. Particularly when the system is overwhelmed with endotoxin, as is the case in severe sepsis, elevated levels of cell-free hemoglobin are associated with increased mortality (55, 56). Interestingly, i.p. injection of globin had protective effects on endotoxemic mice (55), whereas i.v. injection of hemoglobin into endotoxemic mice dramatically increased rates of mortality (56). And although globin alone reduces macrophage TNF production in the presence of LPS, thereby dampening immune response to endotoxin, hemoglobin actually stimulates macrophage TNF production and triggers the release of proinflammatory cytokines under the same conditions (55). The conflicting nature of the hemoglobin literature appears to be due to the dualistic properties of the hemoglobin molecule itself in which, broadly speaking, globins attenuate immune response (55, 57), whereas heme exacerbates it (58, 59). These effects are likely attributable to the ability of globin to scavenge excess free heme during endotoxemia, resulting in attenuated immune activation. In contrast, if heme is inflammatory, injecting hemoglobin could serve to exacerbate this effect.

Heme has also been characterized as a potent danger signal in vitro, capable of activating NF-κB–mediated expression of proinflammatory proteins (including IL-1 and TNF-α), generation of intracellular ROS, 100-fold increase in transcription of proinflammatory genes, and macrophage release of TNF-α and IL-1 (60). It has been suggested that free heme is unable to cause damage on its own but rather produces deleterious effects only in the presence of other immune modulators (61). However, others have demonstrated that free heme is an independent activator of TLR4 (62), stimulating secretion of TNF-α, ROS, and leukotriene B4 from macrophages (59, 62) and release of high mobility group box 1 (HMGB1) from hepatocyte nuclei (58).

Chemokine binding.

A number of studies have revealed that RBCs serve a variety of functions beyond oxygen transport (6, 7, 63, 64) (Table I). One important immunomodulatory property of human erythrocytes is their propensity to bind a wide variety of chemokines (Fig. 2). One major locus for binding is the Duffy Ag receptor for chemokines (DARC), which was first recognized by Darbonne and colleagues (7). This work demonstrated that erythrocytes act as a sink for CXCL8, thereby inactivating the CXCL8-dependent chemokine gradient and preventing neutrophil recruitment (7). Duffy binds other immunomodulatory proteins at high affinity as well, including additional CXC and CC chemokines besides CXCL8 (6, 63). In vitro experiments by Lee et al. (63) demonstrated that blood lacking erythroid Duffy exhibited higher plasma chemokine levels following LPS exposure, further implicating Duffy in chemokine scavenging. This is an evolutionarily conserved feature of DARC, as Duffy knockout mice exhibit higher chemokine (i.e., MIP-2 and KC) concentrations in the lung vascular space (63). Some have proposed that the sequestration of inflammatory molecules by red cell surface receptors functions to dampen immune response via attenuation of neutrophil signaling (7). Such an inhibitory system could confer a selective advantage, as overstimulation of the immune system can generate excessive inflammation and lead to tissue damage.

Table I.
The dualistic nature of RBCs in innate immune function, and its relevance to human disease states
RBC ComponentInnate Immune FunctionPromotes Immune ResponseMaintains Immune QuiescenceRelevant Disease States
DARC Binds chemokines (6, 7, 63Maintains chemokine gradient (64Scavenges and sequesters chemokines (7Critical illness (103
Binds pathogens (83, 91Serves as entry point for P. vivax (83Malaria (8385
 Binds HIV-1 (91HIV (91
TLR9 Binds nucleic acids (5?a Presents mtDNA to immune or endothelial cells (5Scavenges and sequesters inflammatory nucleic acids (5Trauma (5
Results in RBC crenation (5
GYPA Binds pathogens (42, 86, 87?a Facilitates trans-infections Facilitates pathogen destruction via decoy receptor binding (42Malaria (86, 87
Serves as attachment site for P. falciparum (86, 87
Heme/hemoglobin Generates ROS (49, 50Activates TLR4 (62Prevents the growth of yeast and bacteria (52Sepsis (58
Amplifies cytokine production in the presence of LPS (51, 55Staphylococcus infection (46
RBC ComponentInnate Immune FunctionPromotes Immune ResponseMaintains Immune QuiescenceRelevant Disease States
DARC Binds chemokines (6, 7, 63Maintains chemokine gradient (64Scavenges and sequesters chemokines (7Critical illness (103
Binds pathogens (83, 91Serves as entry point for P. vivax (83Malaria (8385
 Binds HIV-1 (91HIV (91
TLR9 Binds nucleic acids (5?a Presents mtDNA to immune or endothelial cells (5Scavenges and sequesters inflammatory nucleic acids (5Trauma (5
Results in RBC crenation (5
GYPA Binds pathogens (42, 86, 87?a Facilitates trans-infections Facilitates pathogen destruction via decoy receptor binding (42Malaria (86, 87
Serves as attachment site for P. falciparum (86, 87
Heme/hemoglobin Generates ROS (49, 50Activates TLR4 (62Prevents the growth of yeast and bacteria (52Sepsis (58
Amplifies cytokine production in the presence of LPS (51, 55Staphylococcus infection (46

Depending on the conditions of the local and systemic microenvironment, immunomodulatory components of human RBCs may function to either repress or promote inflammatory responses.

a

The ? refers to speculated function.

FIGURE 2.

An overview of the binding activities of human erythrocytes. Clockwise from top left. Erythrocytes bind chemokines through DARC, thereby modulating neutrophil recruitment and immune activation. Recent studies have shown that erythrocytes are capable of binding and scavenging mtDNA via TLR9. It is not yet known whether erythroid TLR9 can also scavenge other CpG-rich DNA fragments (e.g., bacterial DNA). Lysed erythrocytes can release heme and hemoglobin into the extracellular environment. In the vicinity of invading microbes, hemoglobin can bind LPS and generate toxic ROS that function in host defense. However, the release of free heme during states of inflammation can result in excessive immune activation, leading to cellular injury or death. GYPA has been identified as a potential decoy receptor on the surface of human erythrocytes, functioning to sequester pathogens and facilitate their removal from circulation.

FIGURE 2.

An overview of the binding activities of human erythrocytes. Clockwise from top left. Erythrocytes bind chemokines through DARC, thereby modulating neutrophil recruitment and immune activation. Recent studies have shown that erythrocytes are capable of binding and scavenging mtDNA via TLR9. It is not yet known whether erythroid TLR9 can also scavenge other CpG-rich DNA fragments (e.g., bacterial DNA). Lysed erythrocytes can release heme and hemoglobin into the extracellular environment. In the vicinity of invading microbes, hemoglobin can bind LPS and generate toxic ROS that function in host defense. However, the release of free heme during states of inflammation can result in excessive immune activation, leading to cellular injury or death. GYPA has been identified as a potential decoy receptor on the surface of human erythrocytes, functioning to sequester pathogens and facilitate their removal from circulation.

Close modal

However, an alternative model for widespread binding of chemokines by DARC may actually result in the maintenance of blood chemokine levels, as chemokines would remain in circulation rather than being cleared. In support of this view, Duffy wild type mice contain significantly higher blood chemokine concentrations than Duffy knockout mice (64). Darbonne’s aforementioned experiments, which concluded that chemokine binding is superficial and easily reversible, may also hint at the potential for sustained immune activation, as erythrocyte receptors could alternately bind and release their substrates in the tissue microenvironment.

These two models for erythrocyte regulation of blood chemokine levels can be termed the sink hypothesis (i.e., erythrocyte chemokine binding serves to diminish immune-activating signals) and the reservoir hypothesis (i.e., erythrocyte binding prevents chemokine clearance, thereby prolonging chemokine half-life in the blood). Although these models appear contradictory at first, they may not be mutually exclusive: Fukuma et al. (64) suggested that erythrocytes do scavenge chemokines from sites of inflammation but eventually release them in response to decreases in plasma chemokine concentration, effectively maintaining homeostasis.

Nucleic acid binding.

In addition to regulating chemokines, recent research demonstrates that erythrocytes are also capable of binding another class of molecules with the potential to mediate inflammatory responses: nucleic acids. Specifically, our recent work has focused on the ability of erythrocytes to bind DNA derived from mitochondria (mtDNA) (5). Mitochondria comprise a sizable endogenous reservoir of potentially inflammatory nucleic acids, which are released into circulation during normal cell turnover by activated immune cells and during cell death. Similar to the DNA of their bacterial ancestors, mtDNA is rich in immunostimulatory CpG motifs and initiates proinflammatory signaling through direct binding of CpG-containing DNA regions to TLR9. Furthermore, mtDNA is known to activate the inflammasome (65, 66), and cytosolic mtDNA is a potent inducer of STING (stimulator of IFN genes), an ER protein that senses a cellular second messenger produced in response to cytosolic dsDNA (6770) and bacterially derived cyclic dinucleotides (67, 71). A growing body of literature implicates these mitochondrial damage-associated molecular patterns (DAMPs) in the pathogenesis of a variety of diseases, including autoimmunity, cancer, cardiovascular disease, trauma, and critical illness (7276).

We recently reported that human erythrocytes express TLR9, potentially providing human erythrocytes with the capacity to scavenge or buffer potentially inflammatory nucleic acids in the circulation (5). Although in nonerythroid cells, TLR9 is trafficked to endolysosomal compartments and cleaved by lysosomal cathepsins to initiate innate immune signaling (7779), it remains unknown whether erythroid surface TLR9 undergoes cleavage and signaling after binding mtDNA. We found that TLR9-positive erythrocytes bind and sequester circulating cell-free mtDNA, and in vivo mouse studies demonstrated that loss of this function results in enhanced lung injury during states of inflammation (5). Additionally, RBCs scavenged CpG DNA from human microvascular endothelial cells in vitro, which may serve to attenuate endothelial TLR9 activation (5).

Notably, there exists significant heterogeneity in erythroid TLR9 expression both between and within individuals (5). Some individuals express relatively high percentages of erythroid TLR9, whereas others express virtually none. Even in those who do express erythroid TLR9, the receptor is only present in a fraction of the total RBC population. Nevertheless, because of the vast number of erythrocytes in circulation [between 20 and 30 trillion in the average adult (1)], even a minority of TLR9-positive cells would have incredible potential to influence systemic function or modulate organ injury.

We are just beginning to understand the ways in which erythrocyte binding of nucleic acids influences systemic function. As in the case of RBC chemokine binding, nucleic acid scavenging may have discrepant effects on inflammation. In some instances, RBCs may attenuate inflammation in the lung compartment by scavenging mtDNA from endothelial cells; however, given the close mechanical contact between erythrocytes and the microvascular endothelium, RBCs binding mtDNA could also exacerbate inflammation by incidentally presenting the inflammatory molecules to immune or endothelial cells. Furthermore, mtDNA binding causes crenation of the erythrocyte membrane, which could result in accelerated clearance of abnormal RBCs or entrapment of the RBCs in the microvasculature.

Although the recent results are consistent with a model in which RBCs scavenge mitochondrial DAMPs from the lung compartment, the dynamics of mtDNA scavenging may be more nuanced. It is possible that, similarly to findings with Duffy Ag and the chemokines that it binds, mtDNA binding could act either as a protective or pathologic mechanism, with the precise impact being largely dependent on the conditions of the local microenvironment.

It is not yet known whether RBCs are also capable of scavenging other types of nucleic acids. However, recent data suggest that Zika RNA may persist on red cells during storage (80). The recent discovery of numerous TLRs (including TLR3) in the transcriptome of mammalian reticulocytes offers a potential mechanism by which this binding could occur and intimates that still other TLRs and nucleic acid scavengers may yet be found on the surface of mature human erythrocytes (81). Furthermore, RBC binding of viral material may be important for disease pathogenesis and may also have implications regarding safe blood storage and transfusion practices.

Pathogen binding.

In addition to their affinity for endogenous molecules like mtDNA and chemokines, human erythrocytes are also known to bind pathogens. Undoubtedly the most infamous and evolutionarily consequential erythrocyte pathogen belongs to the genus Plasmodium, a group of protists responsible for causing malaria. These pathogens have exerted the strongest evolutionary pressures on the human genome in recent millennia (82).

Each Plasmodium species has evolved distinct mechanisms for adhering to human erythrocytes. P. vivax and P. knowlesi attach via the aforementioned DARC (83, 84), rendering the presence of Duffy so maladaptive in high-malaria regions that nearly all West Africans and 68% of African Americans exhibit a Duffy-negative phenotype (85). Clearly, the benefits conferred by Duffy’s ability to scavenge chemokines were dwarfed by its deleterious effects in the presence of malaria, resulting in the spread of the allele conferring Duffy negativity.

The most virulent of the human malarial parasites, P. falciparum, invades erythrocytes after adhering to glycophorin A (GYPA), B, or C (86, 87). Although individuals deficient in any of the glycophorin types exhibit increased resistance to P. falciparum, GYPA paradoxically remains the most common erythrocyte surface protein in humans (12, 42, 88). Complete deficiency of erythrocyte GYPA is a viable but extremely rare phenotype, suggesting that the absence of GYPA must come at a cost (42) or that GYPA’s presence must provide sufficient benefit to override the selective pressure exerted by P. falciparum. Otherwise, P. falciparum would presumably have driven the widespread disappearance of GYPA in malarial regions.

GYPA may act as a decoy receptor, chaperoning pathogens away from important tissues and into the spleen to facilitate their destruction by macrophages (42). In support of this hypothesis, many of the pathogens that bind human glycophorins (e.g., reovirus, influenza C, Sendai, Mycoplasma pneumoniae, Escherichia coli, and Ureaplasma urealyticum) do not infect erythrocytes themselves (42). This could also help explain why GYPA persists on the erythrocyte surface despite selective pressure from P. falciparum. Engineering decoy viral receptors on erythrocytes to facilitate adsorption and prevent invasion of nucleated cells therefore provides a potentially promising approach to clear pathogens from circulation. Indeed, such an approach has been shown to attenuate coxsackievirus B infection in murine models (89).

Unfortunately, not all decoy adsorption has desirable effects. Notably, human erythrocytes bind HIV-1 virions, and this binding results in the 100-fold enrichment of viral infectivity (90). Additionally, HIV-1 binding to DARC on erythrocytes maintains virus viability and presents viral particles to CD4-positive T cells, although these findings have been debated in the literature (9195). In some cases, erythrocyte binding activity may therefore facilitate trans-infections of other viruses as well. As in the case of chemokine and mtDNA binding, local conditions in the bloodstream and the specific interactions between viral ligands and their host receptors may ultimately determine whether erythrocyte pathogen binding proves advantageous or detrimental to the host.

Critical illness.

Given their capacity for interaction with both exogenous and endogenous inflammatory molecules, erythrocytes likely play a major role in the context of critical illness (Fig. 3). During sepsis, the circulation is inundated with excess cell-free nucleic acids, pathogens, and chemokines, all of which have been shown to bind to erythrocytes. Thus, any loss of erythrocyte function has the potential to dramatically alter host response and contribute to the pathogenesis of these conditions.

FIGURE 3.

A systemic model of erythrocyte involvement in critical illness. Under basal conditions, erythrocytes contribute to immune homeostasis by binding and scavenging mtDNA via TLR9. During states of trauma, extensive cell death leads to increased cell-free mtDNA levels. TLR9-positive erythrocytes scavenge these nucleic acids. Erythrocytes binding mtDNA become crenated (i.e., deformed), which could either expedite their clearance from the circulation or trigger the activation of endothelial cells. Unbound mtDNA may engage immune cells, leading to increased inflammation. In sepsis, the circulation is overwhelmed with both bacterial and mtDNA as well as free heme (not shown). It remains unknown whether mtDNA-binding capacity of erythrocytes is reduced during sepsis.

FIGURE 3.

A systemic model of erythrocyte involvement in critical illness. Under basal conditions, erythrocytes contribute to immune homeostasis by binding and scavenging mtDNA via TLR9. During states of trauma, extensive cell death leads to increased cell-free mtDNA levels. TLR9-positive erythrocytes scavenge these nucleic acids. Erythrocytes binding mtDNA become crenated (i.e., deformed), which could either expedite their clearance from the circulation or trigger the activation of endothelial cells. Unbound mtDNA may engage immune cells, leading to increased inflammation. In sepsis, the circulation is overwhelmed with both bacterial and mtDNA as well as free heme (not shown). It remains unknown whether mtDNA-binding capacity of erythrocytes is reduced during sepsis.

Close modal

Research indicates that physical and chemical changes do occur to erythrocytes during periods of sepsis and endotoxemia (96). Septic shock decreases erythrocyte 2,3-bisphosphoglycerate levels, renders them less deformable, and reduces their ability to traverse microvessels (9698).

Crenation of the RBC membrane is another potentially important component of sepsis pathology. This cellular deformation appears to be a consequence of mtDNA binding (5), and elevated levels of cell-free mtDNA during sepsis likely increase the incidence of RBC crenation. We speculate that crenation may expedite RBC clearance and turnover, potentially leading to reduced RBC counts and anemia. Finally, crenated RBCs may also be involved in inflammation, organ failure, tissue ischemia, and vascular occlusion, all of which are central to the sepsis phenotype.

Furthermore, erythrocytes of critically ill trauma patients demonstrate diminished mtDNA scavenging ability (5). This may be highly relevant to the disease pathogenesis of severe sepsis, as recent studies have concluded that elevated levels of plasma mtDNA during critical illness predict mortality (99, 100). The loss of scavenging ability could be attributable to saturation of erythroid TLR9 receptors due to the sheer amount of excess nucleic acids in circulation or to cellular damage incurred by erythrocytes during inflammatory states. Whether defective nucleic acid sequestration by RBCs contributes to the development of lung or other organ injury during sepsis remains unknown. Additionally, future research should aim to determine whether erythroid TLR9 has the ability to bind bacterial CpG DNA in addition to mtDNA, as this could potentially illuminate components of disease pathogenesis.

Cell-free heme is also an important factor in the context of critical illness. In states of infection or inflammation, free heme can act as a DAMP, contributing to excess inflammation, tissue damage, and even death in susceptible hosts (58, 59). Various scavengers of free heme have been identified, and reduced levels of these heme scavengers are also associated with increased mortality (58). One such heme scavenger, heme oxygenase-1 (HO-1), catabolizes free heme and is upregulated following LPS exposure (101). Although the carbon monoxide produced by HO-1 catabolism of heme can be a source of ROS signaling and oxidative stress, the overall effects of the HO-1/CO system are anti-inflammatory because of its reduction of TNF-α, IL-8, and MIP-1β levels and upregulation of IL-12 (101). HO-1 has been shown to be protective in individuals with severe sepsis, suggesting that elevated levels of circulating free heme are central to the pathogenesis of the condition (58). Additionally, low levels of the heme sequestering protein hemopexin (HPX) are associated with increased mortality during sepsis, and administration of HPX during septic shock reduced probability of mortality (58).

Critically ill patients are prone to developing acute respiratory distress syndrome, a life-threatening syndrome characterized by disruption of the alveolar endothelial–epithelial barrier resulting in leakage of proteinaceous fluids into the airspaces, loss of lung compliance, hypoxia, and respiratory failure (102). In preclinical models of lung injury, loss of erythrocyte DARC increased lung inflammation and airspace neutrophil recruitment (103, 104). Consistent with these findings, Kangelaris et al. (105) reported that African American patients possessing a gene polymorphism that abrogates erythroid DARC expression was associated with a 17% increased risk of mortality from acute respiratory distress syndrome compared with patients of European ancestry. African American patients with erythroid DARC, however, fared similarly to European American patients (105). Thus, it is possible that reduced erythrocyte chemokine scavenging function during critical illness may compound inflammation in susceptible hosts.

Malaria.

In the context of malaria, free heme is generated following parasite digestion of hemoglobin. To protect themselves from the cytotoxic effects of heme, P. falciparum parasites convert the compound into an insoluble crystal known as hemozoin. Hemozoin itself is immunologically inert; however, it becomes coated with malarial DNA and subsequently presents the DNA to host TLR9, thereby magnifying the innate immune response (106). Whether erythroid TLR9 is important in the pathogenesis of malaria remains to be investigated.

Appearance of nucleated erythrocytes in disease states.

Finally, it is worth noting that there have been numerous documented cases of nucleated RBCs (NRBCs) circulating in adult humans with severe diseases (32, 33). This is a highly abnormal phenotype, as NRBCs are typically only observed in the peripheral bloodstream of fetuses and neonates (32), yet it is observed in 10 to 30% of critically ill patients (34). Patient prognosis is poor in these cases, with over 50% of individuals dying in the hospital. The presence of NRBCs in the blood has been characterized as an independent predictor of mortality, typically portending death within 1 to 3 wk (33).

Given what is known about the immunologic functions of nucleated erythrocytes in nonmammalian vertebrates, it is tempting to speculate that the reappearance of this evolutionarily ancient trait in humans may serve a functional purpose. For instance, NRBCs could represent a final effort to extrude as many immunologically active cells into circulation as possible in an attempt to overcome a life-threatening insult. Although this is highly speculative, further investigation may uncover previously unrecognized immune activities of human NRBCs.

Altogether, these findings provide mounting evidence that erythrocytes play a direct and significant role in innate immunity and inflammation. Given that erythrocytes are the most abundant cell in the human body (1), they have the capacity to exert substantial effects on immune function. Although this review outlines several immunomodulatory functions of RBCs, the full scope of erythrocyte involvement in the human immune response remains to be defined.

Numerous unanswered questions persist, including whether other pathogen recognition receptors exist on mature RBCs. Furthermore, although the metabolic functions of RBCs are well established, it is unknown whether changes in RBC metabolism may contribute to alterations in immune function. In addition, further investigation into the dualistic nature of erythrocyte immune modulation is required. Research thus far suggests that the utility of RBC binding activities is context dependent, sometimes exacerbating the immune response and sometimes maintaining immune quiescence, but the precise mechanisms and environmental factors moderating this dualism remain enigmatic. Finally, it remains unresolved whether RBC alterations during disease states are the product or the cause of disease pathogenesis.

Further research into the immune functions of erythrocytes will be crucial to understanding not only diseases that affect RBCs directly (e.g., malaria and sickle cell disease) but also chronic and acute inflammatory states where regulation of DAMPs and other mediators is essential for disease control (e.g., sepsis, trauma, and autoimmunity). Given the immune functions of erythrocytes in other vertebrate orders, comparative evolutionary approaches may yield insights into undiscovered functions of erythrocytes in humans. In light of recent findings demonstrating that Zika RNA persists on stored RBCs (80) and the presence of TLR on erythrocytes (5), we stress the importance and urgency of continued research into the immunologic functions of human RBCs.

We thank Dr. Caitlin Clancy for work designing Figs. 13 as well as Dr. Stefano Rivella for constructive feedback during the writing process.

This work was supported by National Institutes of Health Award HL126788 (to N.S.M.). This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Contract W81XWH-15-1-0363 (to N.S.M.).

Abbreviations used in this article:

DAMP

damage-associated molecular pattern

DARC

Duffy Ag receptor for chemokines

GYPA

glycophorin A

HO-1

heme oxygenase-1

mtDNA

mitochondrial DNA

NRBC

nucleated RBC

ROS

reactive oxygen species.

1
Bianconi
,
E.
,
A.
Piovesan
,
F.
Facchin
,
A.
Beraudi
,
R.
Casadei
,
F.
Frabetti
,
L.
Vitale
,
M. C.
Pelleri
,
S.
Tassani
,
F.
Piva
, et al
.
2013
.
An estimation of the number of cells in the human body.
Ann. Hum. Biol.
40
:
463
471
.
2
Moras
,
M.
,
S. D.
Lefevre
,
M. A.
Ostuni
.
2017
.
From erythroblasts to mature red blood cells: organelle clearance in mammals.
Front. Physiol.
8
:
1076
.
3
de Back
,
D. Z.
,
E. B.
Kostova
,
M.
van Kraaij
,
T. K.
van den Berg
,
R.
van Bruggen
.
2014
.
Of macrophages and red blood cells; a complex love story.
Front. Physiol.
5
:
9
.
4
Ji
,
P.
,
M.
Murata-Hori
,
H. F.
Lodish
.
2011
.
Formation of mammalian erythrocytes: chromatin condensation and enucleation.
Trends Cell Biol.
21
:
409
415
.
5
Hotz
,
M. J.
,
D.
Qing
,
M. G. S.
Shashaty
,
P.
Zhang
,
H.
Faust
,
N.
Sondheimer
,
S.
Rivella
,
G. S.
Worthen
,
N. S.
Mangalmurti
.
2018
.
Red Blood Cells homeostatically bind mtDNA through TLR9 to maintain quiescence and prevent lung injury.
Am. J. Respir. Crit. Care Med.
197
:
470
480
.
6
Neote
,
K.
,
W.
Darbonne
,
J.
Ogez
,
R.
Horuk
,
T. J.
Schall
.
1993
.
Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells.
J. Biol. Chem.
268
:
12247
12249
.
7
Darbonne
,
W. C.
,
G. C.
Rice
,
M. A.
Mohler
,
T.
Apple
,
C. A.
Hébert
,
A. J.
Valente
,
J. B.
Baker
.
1991
.
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
J. Clin. Invest.
88
:
1362
1369
.
8
Passantino
,
L.
,
M.
Altamura
,
A.
Cianciotta
,
F.
Jirillo
,
M. R.
Ribaud
,
E.
Jirillo
,
G. F.
Passantino
.
2004
.
Maturation of fish erythrocytes coincides with changes in their morphology, enhanced ability to interact with Candida albicans and release of cytokine-like factors active upon autologous macrophages.
Immunopharmacol. Immunotoxicol.
26
:
573
585
.
9
Passantino
,
L.
,
M. A.
Massaro
,
F.
Jirillo
,
D.
Di Modugno
,
M. R.
Ribaud
,
G. D.
Modugno
,
G. F.
Passantino
,
E.
Jirillo
.
2007
.
Antigenically activated avian erythrocytes release cytokine-like factors: a conserved phylogenetic function discovered in fish.
Immunopharmacol. Immunotoxicol.
29
:
141
152
.
10
Workenhe
,
S. T.
,
M. J. T.
Kibenge
,
G. M.
Wright
,
D. W.
Wadowska
,
D. B.
Groman
,
F. S. B.
Kibenge
.
2008
.
Infectious salmon anaemia virus replication and induction of alpha interferon in Atlantic salmon erythrocytes.
Virol. J.
5
:
36
.
11
Dahle
,
M. K.
,
Ø.
Wessel
,
G.
Timmerhaus
,
I. B.
Nyman
,
S. M.
Jørgensen
,
E.
Rimstad
,
A.
Krasnov
.
2015
.
Transcriptome analyses of Atlantic salmon (Salmo salar L.) erythrocytes infected with piscine orthoreovirus (PRV).
Fish Shellfish Immunol.
45
:
780
790
.
12
Passantino
,
L.
,
M.
Altamura
,
A.
Cianciotta
,
R.
Patruno
,
A.
Tafaro
,
E.
Jirillo
,
G. F.
Passantino
.
2002
.
Fish immunology. I. Binding and engulfment of Candida albicans by erythrocytes of rainbow trout (Salmo gairdneri Richardson).
Immunopharmacol. Immunotoxicol.
24
:
665
678
.
13
Sinclair
,
G. D.
,
K.
Brasch
.
1975
.
The nucleated erythrocyte: a model of cell differentiation.
Rev. Can. Biol.
34
:
287
303
.
14
Rodriguez
,
M. F.
,
G. D.
Wiens
,
M. K.
Purcell
,
Y.
Palti
.
2005
.
Characterization of Toll-like receptor 3 gene in rainbow trout (Oncorhynchus mykiss).
Immunogenetics
57
:
510
519
.
15
Morera
,
D.
,
S. A.
MacKenzie
.
2011
.
Is there a direct role for erythrocytes in the immune response?
Vet. Res. (Faisalabad)
42
:
89
.
16
Lund
,
S. G.
,
M. C. L.
Phillips
,
C. D.
Moyes
,
B. L.
Tufts
.
2000
.
The effects of cell ageing on protein synthesis in rainbow trout (Oncorhynchus mykiss) red blood cells.
J. Exp. Biol.
203
:
2219
2228
.
17
Jiang
,
J.
,
C.
Wu
,
H.
Gao
,
J.
Song
,
H.
Li
.
2010
.
Effects of astragalus polysaccharides on immunologic function of erythrocyte in chickens infected with infectious bursa disease virus.
Vaccine
28
:
5614
5616
.
18
Jeong
,
J.-M.
,
C. M.
An
,
M.-C.
Kim
,
C.-I.
Park
.
2016
.
Cooperation of erythrocytes with leukocytes in immune response of a teleost Oplegnathus fasciatus.
Genes Genomics
38
:
931
938
.
19
Harrington
,
D. B.
,
R. O.
Becker
.
1973
.
Electrical stimulation of RNA and protein synthesis in the frog erythrocyte.
Exp. Cell Res.
76
:
95
98
.
20
Chen
,
Q.
,
A.
Barragan
,
V.
Fernandez
,
A.
Sundström
,
M.
Schlichtherle
,
A.
Sahlén
,
J.
Carlson
,
S.
Datta
,
M.
Wahlgren
.
1998
.
Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum.
J. Exp. Med.
187
:
15
23
.
21
Millar
,
D. A.
,
N. A.
Ratcliffe
.
1989
.
The evolution of blood cells: facts and enigmas.
Endeavour
13
:
72
77
.
22
Cooper
,
E. L.
1976
.
Evolution of blood cells.
Ann. Immunol. (Paris)
127
:
817
825
.
23
Monahan-Earley
,
R.
,
A. M.
Dvorak
,
W. C.
Aird
.
2013
.
Evolutionary origins of the blood vascular system and endothelium.
J. Thromb. Haemost.
11
(
Suppl. 1
):
46
66
.
24
Snyder
,
G.
,
B.
Sheafor
.
1999
.
Red blood cells: centerpiece in the evolution of the vertebrate.
Am. Zool.
39
:
189
198
.
25
Mangum
,
C. P.
1998
.
Major events in the evolution of the oxygen carriers.
Am. Zool.
38
:
1
13
.
26
di Prisco
,
G.
,
E.
Cocca
,
S.
Parker
,
H.
Detrich
III
.
2002
.
Tracking the evolutionary loss of hemoglobin expression by the white-blooded Antarctic icefishes.
Gene
295
:
185
191
.
27
Weber
,
R. E.
,
S. N.
Vinogradov
.
2001
.
Nonvertebrate hemoglobins: functions and molecular adaptations.
Physiol. Rev.
81
:
569
628
.
28
Wingstrand
,
K. G.
1956
.
Non-nucleated erythrocytes in a teleostean fish Maurolicus mülleri (Gmelin).
Z. Zellforsch. Mikrosk. Anat.
45
:
195
200
.
29
Mueller
,
R. L.
,
T. R.
Gregory
,
S. M.
Gregory
,
A.
Hsieh
,
J. L.
Boore
.
2008
.
Genome size, cell size, and the evolution of enucleated erythrocytes in attenuate salamanders.
Zoology (Jena).
111
:
218
230
.
30
Emmel
,
V. E.
1924
.
Studies on the non-nucleated elements of the blood.
Am. J. Anat.
33
:
347
405
.
31
Morera
,
D.
,
N.
Roher
,
L.
Ribas
,
J. C.
Balasch
,
C.
Doñate
,
A.
Callol
,
S.
Boltaña
,
S.
Roberts
,
G.
Goetz
,
F. W.
Goetz
,
S. A.
MacKenzie
.
2011
.
RNA-Seq reveals an integrated immune response in nucleated erythrocytes.
PLoS One
6
:
e26998
.
32
Schaer
,
C.
,
M.
Schmugge
,
B.
Frey
.
2014
.
Prognostic value of nucleated red blood cells in critically ill children.
Swiss Med. Wkly.
144
:
w13944
.
33
Stachon
,
A.
,
E.
Segbers
,
T.
Holland-Letz
,
R.
Kempf
,
S.
Hering
,
M.
Krieg
.
2007
.
Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study.
Crit. Care
11
:
R62
.
34
Purtle
,
S. W.
,
C. M.
Horkan
,
T.
Moromizato
,
F. K.
Gibbons
,
K. B.
Christopher
.
2017
.
Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study.
Crit. Care
21
:
154
.
35
Blatter
,
D.
,
B.
Lui
,
D.
Stone
,
B.
Wyatt
.
The denucleation of the mammalian erythrocyte: an evolutionary mechanism.
Available at: http://www.math.utah.edu/∼davis/REUwriteup.pdf. Accessed: December 18, 2017.
36
Javanbakht
,
H.
,
S.
Vaissi
,
P.
Parto
.
2013
.
The morphological characterization of the blood cells in the three species of turtle and tortoise in Iran.
Res. Zool.
3
:
38
44
.
37
Long
,
C. A.
2007
. Evolution of function and form in camelid erythrocytes. In Bio'07: Proceedings of the 3rd WSEAS International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering, August 26–28. Vouliagmeni, Athens, Greece, p.
18
24
.
38
Glomski
,
C. A.
,
J.
Tamburlin
,
R.
Hard
,
M.
Chainani
.
1997
.
The phylogenetic odyssey of the erythrocyte. IV. The amphibians.
Histol. Histopathol.
12
:
147
170
.
39
Zhang
,
Z. W.
,
J.
Cheng
,
F.
Xu
,
Y. E.
Chen
,
J. B.
Du
,
M.
Yuan
,
F.
Zhu
,
X. C.
Xu
,
S.
Yuan
.
2011
.
Red blood cell extrudes nucleus and mitochondria against oxidative stress.
IUBMB Life
63
:
560
565
.
40
Kuhn
,
V.
,
L.
Diederich
,
T. C. S.
Keller
IV
,
C. M.
Kramer
,
W.
Lückstädt
,
C.
Panknin
,
T.
Suvorava
,
B. E.
Isakson
,
M.
Kelm
,
M. M.
Cortese-Krott
.
2017
.
Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia.
Antioxid. Redox Signal.
26
:
718
742
.
41
Stier
,
A.
,
P.
Bize
,
Q.
Schull
,
J.
Zoll
,
F.
Singh
,
B.
Geny
,
F.
Gros
,
C.
Royer
,
S.
Massemin
,
F.
Criscuolo
.
2013
.
Avian erythrocytes have functional mitochondria, opening novel perspectives for birds as animal models in the study of ageing.
Front. Zool.
10
:
33
.
42
Baum
,
J.
,
R. H.
Ward
,
D. J.
Conway
.
2002
.
Natural selection on the erythrocyte surface.
Mol. Biol. Evol.
19
:
223
229
.
43
Payne
,
S. M.
1993
.
Iron acquisition in microbial pathogenesis.
Trends Microbiol.
1
:
66
69
.
44
Cassat
,
J. E.
,
E. P.
Skaar
.
2013
.
Iron in infection and immunity.
Cell Host Microbe
13
:
509
519
.
45
Pishchany
,
G.
,
E. P.
Skaar
.
2012
.
Taste for blood: hemoglobin as a nutrient source for pathogens.
PLoS Pathog.
8
:
e1002535
.
46
Skaar
,
E. P.
,
M.
Humayun
,
T.
Bae
,
K. L.
DeBord
,
O.
Schneewind
.
2004
.
Iron-source preference of Staphylococcus aureus infections.
Science
305
:
1626
1628
.
47
Deriu
,
E.
,
J. Z.
Liu
,
M.
Pezeshki
,
R. A.
Edwards
,
R. J.
Ochoa
,
H.
Contreras
,
S. J.
Libby
,
F. C.
Fang
,
M.
Raffatellu
.
2013
.
Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.
Cell Host Microbe
14
:
26
37
.
48
Diaz-ochoa
,
V. E.
,
S.
Jellbauer
,
S.
Klaus
,
M.
Raffatellu
.
2014
.
Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis.
Front Cell Infect. Microbiol.
4
:
2
.
49
Jiang
,
N.
,
N. S.
Tan
,
B.
Ho
,
J. L.
Ding
.
2007
.
Respiratory protein-generated reactive oxygen species as an antimicrobial strategy.
Nat. Immunol.
8
:
1114
1122
.
50
Bahl
,
N.
,
R.
Du
,
I.
Winarsih
,
B.
Ho
,
L.
Tucker-Kellogg
,
B.
Tidor
,
J. L.
Ding
.
2011
.
Delineation of lipopolysaccharide (LPS)-binding sites on hemoglobin: from in silico predictions to biophysical characterization.
J. Biol. Chem.
286
:
37793
37803
.
51
Bodet
,
C.
,
F.
Chandad
,
D.
Grenier
.
2007
.
Hemoglobin and LPS act in synergy to amplify the inflammatory response.
J. Dent. Res.
86
:
878
882
.
52
Liepke
,
C.
,
S.
Baxmann
,
C.
Heine
,
N.
Breithaupt
,
L.
Ständker
,
W. G.
Forssmann
.
2003
.
Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
791
:
345
356
.
53
Iwanaga
,
S.
2002
.
The molecular basis of innate immunity in the horseshoe crab.
Curr. Opin. Immunol.
14
:
87
95
.
54
Fogaça
,
A. C.
,
P. I.
da Silva
Jr.
,
M. T.
Miranda
,
A. G.
Bianchi
,
A.
Miranda
,
P. E.
Ribolla
,
S.
Daffre
.
1999
.
Antimicrobial activity of a bovine hemoglobin fragment in the tick Boophilus microplus.
J. Biol. Chem.
274
:
25330
25334
.
55
Yang
,
H.
,
H.
Wang
,
T. R.
Bernik
,
S.
Ivanova
,
H.
Wang
,
L.
Ulloa
,
J.
Roth
,
J. W.
Eaton
,
K. J.
Tracey
.
2002
.
Globin attenuates the innate immune response to endotoxin.
Shock
17
:
485
490
.
56
Su
,
D.
,
R. I.
Roth
,
M.
Yoshida
,
J.
Levin
.
1997
.
Hemoglobin increases mortality from bacterial endotoxin.
Infect. Immun.
65
:
1258
1266
.
57
Parish
,
C. A.
,
H.
Jiang
,
Y.
Tokiwa
,
N.
Berova
,
K.
Nakanishi
,
D.
McCabe
,
W.
Zuckerman
,
M. M.
Xia
,
J. E.
Gabay
.
2001
.
Broad-spectrum antimicrobial activity of hemoglobin.
Bioorg. Med. Chem.
9
:
377
382
.
58
Larsen
,
R.
,
R.
Gozzelino
,
V.
Jeney
,
L.
Tokaji
,
F. A.
Bozza
,
A. M.
Japiassú
,
D.
Bonaparte
,
M. M.
Cavalcante
,
A.
Chora
,
A.
Ferreira
, et al
.
2010
.
A central role for free heme in the pathogenesis of severe sepsis.
Sci. Transl. Med.
2
:
51ra71
.
59
Neal
,
M. D.
,
J. S.
Raval
,
D. J.
Triulzi
,
R. L.
Simmons
.
2013
.
Innate immune activation after transfusion of stored red blood cells.
Transfus. Med. Rev.
27
:
113
118
.
60
Hao
,
K.
,
H.
Hanawa
,
L.
Ding
,
Y.
Ota
,
K.
Yoshida
,
K.
Toba
,
M.
Ogura
,
H.
Ito
,
M.
Kodama
,
Y.
Aizawa
.
2011
.
Free heme is a danger signal inducing expression of proinflammatory proteins in cultured cells derived from normal rat hearts.
Mol. Immunol.
48
:
1191
1202
.
61
Larsen
,
R.
,
Z.
Gouveia
,
M. P.
Soares
,
R.
Gozzelino
.
2012
.
Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases.
Front. Pharmacol.
3
:
77
.
62
Figueiredo
,
R. T.
,
P. L.
Fernandez
,
D. S.
Mourao-Sa
,
B. N.
Porto
,
F. F.
Dutra
,
L. S.
Alves
,
M. F.
Oliveira
,
P. L.
Oliveira
,
A. V.
Graça-Souza
,
M. T.
Bozza
.
2007
.
Characterization of heme as activator of Toll-like receptor 4.
J. Biol. Chem.
282
:
20221
20229
.
63
Lee
,
J. S.
,
M. M.
Wurfel
,
G.
Matute-Bello
,
C. W.
Frevert
,
M. R.
Rosengart
,
M.
Ranganathan
,
V. W.
Wong
,
T.
Holden
,
S.
Sutlief
,
A.
Richmond
,
S.
Peiper
, et al
.
2006
.
The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation.
J. Immuno.
177
:
8086
8094
.
64
Fukuma
,
N.
,
N.
Akimitsu
,
H.
Hamamoto
,
H.
Kusuhara
,
Y.
Sugiyama
,
K.
Sekimizu
.
2003
.
A role of the Duffy antigen for the maintenance of plasma chemokine concentrations.
Biochem. Biophys. Res. Commun.
303
:
137
139
.
65
Nakahira
,
K.
,
J. A.
Haspel
,
V. A. K.
Rathinam
,
S.-J.
Lee
,
T.
Dolinay
,
H. C.
Lam
,
J. A.
Englert
,
M.
Rabinovitch
,
M.
Cernadas
,
H. P.
Kim
, et al
.
2011
.
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.
Nat. Immunol.
12
:
222
230
.
66
Shimada
,
K.
,
T. R.
Crother
,
J.
Karlin
,
J.
Dagvadorj
,
N.
Chiba
,
S.
Chen
,
V. K.
Ramanujan
,
A. J.
Wolf
,
L.
Vergnes
,
D. M.
Ojcius
, et al
.
2012
.
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis.
Immunity
36
:
401
414
.
67
West
,
A. P.
,
W.
Khoury-Hanold
,
M.
Staron
,
M. C.
Tal
,
C. M.
Pineda
,
S. M.
Lang
,
M.
Bestwick
,
B. A.
Duguay
,
N.
Raimundo
,
D. A.
MacDuff
, et al
.
2015
.
Mitochondrial DNA stress primes the antiviral innate immune response.
Nature
520
:
553
557
.
68
Zhang
,
X.
,
H.
Shi
,
J.
Wu
,
X.
Zhang
,
L.
Sun
,
C.
Chen
,
Z. J.
Chen
.
2013
.
Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING.
Mol. Cell
51
:
226
235
.
69
Chen
,
Q.
,
L.
Sun
,
Z. J.
Chen
.
2016
.
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing.
Nat. Immunol.
17
:
1142
1149
.
70
Zhang
,
X.
,
J.
Wu
,
F.
Du
,
H.
Xu
,
L.
Sun
,
Z.
Chen
,
C. A.
Brautigam
,
X.
Zhang
,
Z. J.
Chen
.
2014
.
The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop.
Cell Rep.
6
:
421
430
.
71
Rongvaux
,
A.
,
R.
Jackson
,
C. C. D.
Harman
,
T.
Li
,
A. P.
West
,
M. R.
de Zoete
,
Y.
Wu
,
B.
Yordy
,
S. A.
Lakhani
,
C. Y.
Kuan
, et al
.
2014
.
Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA.
Cell
159
:
1563
1577
.
72
Snyder
,
M. W.
,
M.
Kircher
,
A. J.
Hill
,
R. M.
Daza
,
J.
Shendure
.
2016
.
Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin.
Cell
164
:
57
68
.
73
Garcia-Martinez
,
I.
,
N.
Santoro
,
Y.
Chen
,
R.
Hoque
,
X.
Ouyang
,
S.
Caprio
,
M. J.
Shlomchik
,
R. L.
Coffman
,
A.
Candia
,
W. Z.
Mehal
.
2016
.
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.
J. Clin. Invest.
126
:
859
864
.
74
Bao
,
W.
,
H.
Xia
,
Y.
Liang
,
Y.
Ye
,
Y.
Lu
,
X.
Xu
,
A.
Duan
,
J.
He
,
Z.
Chen
,
Y.
Wu
, et al
.
2016
.
Toll-like receptor 9 can be activated by endogenous mitochondrial DNA to induce podocyte apoptosis.
Sci. Rep.
6
:
22579
.
75
Zhang
,
J. Z.
,
Z.
Liu
,
J.
Liu
,
J. X.
Ren
,
T. S.
Sun
.
2014
.
Mitochondrial DNA induces inflammation and increases TLR9/NF-κB expression in lung tissue.
Int. J. Mol. Med.
33
:
817
824
.
76
Zhang
,
Q.
,
M.
Raoof
,
Y.
Chen
,
Y.
Sumi
,
T.
Sursal
,
W.
Junger
,
K.
Brohi
,
K.
Itagaki
,
C. J.
Hauser
.
2010
.
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
Nature
464
:
104
107
.
77
Ewald
,
S. E.
,
B. L.
Lee
,
L.
Lau
,
K. E.
Wickliffe
,
G. P.
Shi
,
H. A.
Chapman
,
G. M.
Barton
.
2008
.
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.
Nature
456
:
658
662
.
78
Ewald
,
S. E.
,
A.
Engel
,
J.
Lee
,
M.
Wang
,
M.
Bogyo
,
G. M.
Barton
.
2011
.
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.
J. Exp. Med.
208
:
643
651
.
79
Mouchess
,
M. L.
,
N.
Arpaia
,
G.
Souza
,
R.
Barbalat
,
S. E.
Ewald
,
L.
Lau
,
G. M.
Barton
.
2011
.
Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation.
Immunity
35
:
721
732
.
80
Stone
,
M.
,
S.
Bakkour
,
T.-H.
Lee
,
M.
Lanteri
,
G.
Simmons
,
D.
Brambilla
,
J. O.
Alsina
,
P. C.
Williamson
,
R. A.
Reik
,
S. A.
Galel
, et al
.
2017
.
Zika RNA persistence in blood and body fluids and clinical outcomes in infected blood donors.
Transfusion
57
:
4A
.
81
Liang
,
R.
,
G.
Campreciós
,
Y.
Kou
,
K.
McGrath
,
R.
Nowak
,
S.
Catherman
,
C. L.
Bigarella
,
P.
Rimmelé
,
X.
Zhang
,
M. N.
Gnanapragasam
, et al
.
2015
.
A systems approach identifies essential FOXO3 functions at key steps of terminal erythropoiesis.
PLoS Genet.
11
:
e1005526
.
82
Kwiatkowski
,
D. P.
2005
.
How malaria has affected the human genome and what human genetics can teach us about malaria.
Am. J. Hum. Genet.
77
:
171
192
.
83
Horuk
,
R.
,
C. E.
Chitnis
,
W. C.
Darbonne
,
T. J.
Colby
,
A.
Rybicki
,
T. J.
Hadley
,
L. H.
Miller
.
1993
.
A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor.
Science
261
:
1182
1184
.
84
McHenry
,
A. M.
,
J. H.
Adams
.
2006
.
The crystal structure of P. knowlesi DBPalpha DBL domain and its implications for immune evasion.
Trends Biochem. Sci.
31
:
487
491
.
85
Mourant
,
A. E.
,
A. C.
Kopeć
,
K.
Domaniewska-Sobczak
.
1977
.
The Distrubtion of Human Blood Groups and Other Polymorphisms
, 2nd Ed.
Oxford University Press
,
London, UK
.
86
Facer
,
C. A.
1983
.
Merozoites of P. falciparum require glycophorin for invasion into red cells.
Bull. Soc. Pathol. Exot.
76
:
463
469
.
87
Cowman
,
A. F.
,
D.
Berry
,
J.
Baum
.
2012
.
The cellular and molecular basis for malaria parasite invasion of the human red blood cell.
J. Cell Biol.
198
:
961
971
.
88
Poole
,
J.
2000
.
Red cell antigens on band 3 and glycophorin A.
Blood Rev.
14
:
31
43
.
89
Asher
,
D. R.
,
A. M.
Cerny
,
R. W.
Finberg
.
2005
.
The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection.
Proc. Natl. Acad. Sci. USA
102
:
12897
12902
.
90
Beck
,
Z.
,
B. K.
Brown
,
L.
Wieczorek
,
K. K.
Peachman
,
G. R.
Matyas
,
V. R.
Polonis
,
M.
Rao
,
C. R.
Alving
.
2009
.
Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
PLoS One
4
:
e8297
.
91
He
,
W.
,
S.
Neil
,
H.
Kulkarni
,
E.
Wright
,
B. K.
Agan
,
V. C.
Marconi
,
M. J.
Dolan
,
R. A.
Weiss
,
S. K.
Ahuja
.
2008
.
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.
Cell Host Microbe
4
:
52
62
.
92
Winkler
,
C. A.
,
P.
An
,
R.
Johnson
,
G. W.
Nelson
,
G.
Kirk
.
2009
.
Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans.
Cell Host Microbe
5
:
411
413
; author reply 418–419.
93
Walley, N. M., B. Julg, S. P. Dickson, J. Fellay, D. Ge, B. D. Walker, M. Carrington, M. S. Cohen, P. I. de Bakker, D. B. Goldstein, et al. 2009. The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe 5: 408–410; author reply 418–409. 10.1016/j.chom.2009.04.011
94
Julg
,
B.
,
S.
Reddy
,
M.
van der Stok
,
S.
Kulkarni
,
Y.
Qi
,
S.
Bass
,
B.
Gold
,
M. A.
Nalls
,
G. W.
Nelson
,
B. D.
Walker
, et al
.
2009
.
Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population.
Cell Host Microbe
5
:
413
415
; author reply 418–419.
95
Horne
,
K. C.
,
X.
Li
,
L. P.
Jacobson
,
F.
Palella
,
B. D.
Jamieson
,
J. B.
Margolick
,
J.
Martinson
,
V.
Turkozu
,
K.
Visvanathan
,
I. J.
Woolley
.
2009
.
Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort.
Cell Host Microbe
5
:
415
417
; author reply 418–419.
96
Bateman
,
R. M.
,
M. D.
Sharpe
,
M.
Singer
,
C. G.
Ellis
.
2017
.
The effect of sepsis on the erythrocyte.
Int. J. Mol. Sci.
18
.
1932
.
97
Baskurt
,
O. K.
,
D.
Gelmont
,
H. J.
Meiselman
.
1998
.
Red blood cell deformability in sepsis.
Am. J. Respir. Crit. Care Med.
157
:
421
427
.
98
Machiedo
,
G. W.
,
R. J.
Powell
,
B. F.
Rush
Jr.
,
N. I.
Swislocki
,
G.
Dikdan
.
1989
.
The incidence of decreased red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure.
Arch. Surg.
124
:
1386
1389
.
99
Nakahira
,
K.
,
S. Y.
Kyung
,
A. J.
Rogers
,
L.
Gazourian
,
S.
Youn
,
A. F.
Massaro
,
C.
Quintana
,
J. C.
Osorio
,
Z.
Wang
,
Y.
Zhao
, et al
.
2013
.
Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.
PLoS Med.
10
:
e1001577
; discussion e1001577.
100
Simmons
,
J. D.
,
Y. L.
Lee
,
S.
Mulekar
,
J. L.
Kuck
,
S. B.
Brevard
,
R. P.
Gonzalez
,
M. N.
Gillespie
,
W. O.
Richards
.
2013
.
Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects.
Ann. Surg.
258
:
591
596
; discussion 596–598.
101
Cherry
,
A. D.
,
C. A.
Piantadosi
.
2015
.
Regulation of mitochondrial biogenesis and its intersection with inflammatory responses.
Antioxid. Redox Signal.
22
:
965
976
.
102
Ranieri
,
V. M.
,
G. D.
Rubenfeld
,
B. T.
Thompson
,
N. D.
Ferguson
,
E.
Caldwell
,
E.
Fan
,
L.
Camporota
,
A. S.
Slutsky
;
ARDS Definition Task Force
.
2012
.
Acute respiratory distress syndrome: the Berlin Definition.
JAMA
307
:
2526
2533
.
103
Mangalmurti
,
N. S.
,
Z.
Xiong
,
M.
Hulver
,
M.
Ranganathan
,
X. H.
Liu
,
T.
Oriss
,
M.
Fitzpatrick
,
M.
Rubin
,
D.
Triulzi
,
A.
Choi
,
J. S.
Lee
.
2009
.
Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation.
Blood
113
:
1158
1166
.
104
Reutershan
,
J.
,
B.
Harry
,
D.
Chang
,
G. J.
Bagby
,
K.
Ley
.
2009
.
DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines.
Eur. J. Immunol.
39
:
1597
1607
.
105
Kangelaris
,
K. N.
,
A.
Sapru
,
C. S.
Calfee
,
K. D.
Liu
,
L.
Pawlikowska
,
J. S.
Witte
,
E.
Vittinghoff
,
H.
Zhuo
,
A. D.
Auerbach
,
E.
Ziv
,
M. A.
Matthay
;
National Heart, Lung, and Blood Institute ARDS Network
.
2012
.
The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury.
Chest
141
:
1160
1169
.
106
Parroche
,
P.
,
F. N.
Lauw
,
N.
Goutagny
,
E.
Latz
,
B. G.
Monks
,
A.
Visintin
,
K. A.
Halmen
,
M.
Lamphier
,
M.
Olivier
,
D. C.
Bartholomeu
, et al
.
2007
.
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9.
Proc. Natl. Acad. Sci. USA
104
:
1919
1924
.

The authors have no financial conflicts of interest.